openPR Logo

Press Releases from DelveInsight Business Research (5349 total)

Uncomplicated Urinary Tract Infections Clinical Trials 2024: EMA, PDMA, FDA Appr …

(Albany, United States) As per DelveInsight's assessment, globally, Uncomplicated Urinary Tract Infections pipeline constitutes 5+ key companies continuously working towards developing 5+ Uncomplicated Urinary Tract

Cervical Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

(Albany, USA) DelveInsight's, "Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It

Alzheimer's Disease Pipeline Drugs 2024: Clinical Trials, EMA, PDMA, FDA Approva …

(Albany, United States) As per DelveInsight's assessment, globally, Alzheimer's Disease pipeline constitutes 110+ key companies continuously working towards developing 120+ Alzheimer's Disease treatment therapies, analysis

Neurotrophic Keratitis Pipeline Analysis 2024: FDA Approvals, Clinical Trials, T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neurotrophic Keratitis pipeline constitutes 4+ key companies continuously working towards developing 4+ Neurotrophic Keratitis treatment

Vernal Keratoconjunctivitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medi …

(Albany, United States) As per DelveInsight's assessment, globally, Vernal Keratoconjunctivitis pipeline constitutes 5+ key companies continuously working towards developing 5+ Vernal Keratoconjunctivitis treatment therapies, analysis

Myasthenia Gravis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Th …

(Albany, USA) As per DelveInsight's assessment, about 20+ key pharma and biotech companies are working on 20+ pipeline drugs in the Myasthenia Gravis therapeutics landscape

Myelodysplastic Syndrome Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …

DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2024" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the

Spastic Cerebral Palsy Pipeline Overview 2024: FDA Approvals, Analysis of Clinic …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Spastic Cerebral Palsy pipeline constitutes key companies continuously working towards developing Spastic Cerebral Palsy

Charcot Marie Tooth Disease Pipeline Analysis 2024: FDA Approvals and Emerging T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Charcot Marie Tooth Disease pipeline constitutes 10+ key companies continuously working towards developing 15+

Checkpoint Inhibitor Refractory Cancer Market Forecasted to Surge in Coming Year …

DelveInsight's "Checkpoint Inhibitor Refractory Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Checkpoint Inhibitor Refractory Cancer, historical and forecasted

Duchenne Muscular Dystrophy Pipeline Insights 2024: Therapies, Clinical Trials, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Duchenne Muscular Dystrophy pipeline constitutes 75+ key companies continuously working towards developing 75+ Duchenne

Dyslipidemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Dyslipidemia pipeline constitutes key companies continuously working towards developing Dyslipidemia treatment therapies, analysis of

Alcohol Use Disorder Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …

(Albany, USA) DelveInsight's, "Alcohol Use Disorder Pipeline Insight, 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline

Adeno-Associated Virus (AAV) Vectors in Gene Therapy Clinical Trials 2024: EMA, …

(Albany, USA) DelveInsight's, "AAV Vectors in Gene Therapy Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 235+ pipeline drugs in AAV vectors

Adrenocortical Carcinoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicat …

(Albany, United States) As per DelveInsight's assessment, globally, Adrenocortical Carcinoma pipeline constitutes 5+ key companies continuously working towards developing 5+ Adrenocortical Carcinoma treatment therapies, analysis

Acute Lymphocytic Leukemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medic …

(Albany, USA) DelveInsight's, "Acute Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 150+ companies and 160+ pipeline drugs in the Acute Lymphocytic Leukemia

Age-related Vision Dysfunction Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …

(Albany, United States) As per DelveInsight's assessment, globally, Age-related Vision Dysfunction pipeline constitutes 8+ key companies continuously working towards developing 8+ Age-related Vision Dysfunction treatment

Chlamydia Infections Clinical Trials 2024: FDA Approvals, Clinical Trials, Thera …

(Albany, USA) DelveInsight's, "Chlamydia Infections Pipeline Insight, 2024," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia Infections pipeline landscape. It

Treatment Resistant Depression Pipeline Analysis 2024: FDA Approvals, Clinical T …

(Albany, United States) As per DelveInsight's assessment, globally, Treatment Resistant Depression pipeline constitutes 25+ key companies continuously working towards developing 25+ Treatment Resistant Depression treatment

Usher Syndrome Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Trials …

(Albany, United States) As per DelveInsight's assessment, globally, Usher Syndrome pipeline constitutes 5+ key companies continuously working towards developing 7+ Usher Syndrome treatment therapies, analysis

Renal Tubular Acidosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Renal Tubular Acidosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Renal Tubular Acidosis treatment

Venous Thromboembolism Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Venous Thromboembolism pipeline constitutes 10+ key companies continuously working towards developing 10+ Venous Thromboembolism treatment therapies, analysis

Exocrine Pancreatic Insufficiency Clinical Trials 2024: EMA, PDMA, FDA Approvals …

(Albany, United States) As per DelveInsight's assessment, globally, Exocrine Pancreatic Insufficiency pipeline constitutes 5+ key companies continuously working towards developing 5+ Exocrine Pancreatic Insufficiency treatment

Bullous Pemphigoid Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …

(Albany, United States) As per DelveInsight's assessment, globally, Bullous pemphigoid pipeline constitutes 4+ key companies continuously working towards developing 4+ Bullous pemphigoid treatment therapies, analysis

Post Bariatric Hypoglycemia Market Forecasted to Surge in Coming Years, 2024-203 …

DelveInsight's "Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Bariatric Hypoglycemia, historical and forecasted epidemiology as

Oligometastatic Disease Market Report 2034: Epidemiology Data, Pipeline Therapie …

DelveInsight's "Oligometastatic Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Oligometastatic Disease, historical and forecasted epidemiology as well as

Parkinson's Disease Psychosis Pipeline Update 2024: FDA Approvals, Therapeutic A …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Parkinson's Disease Psychosis pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's

Ovarian Cancer Pipeline Assessment 2024: Therapies, Clinical Trials, Latest FDA, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Ovarian Cancer pipeline constitutes 180+ key companies continuously working towards developing 200+ Ovarian Cancer

PH-ILD Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, PH-ILD pipeline constitutes key companies continuously working towards developing PH-ILD treatment therapies, analysis of

Hepatitis C Virus Infection Pipeline Forecast 2024: FDA Approvals: Analysis of C …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hepatitis C Virus Infection pipeline constitutes 20+ key companies continuously working towards developing 20+

Herpes Simplex Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, T …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Herpes Simplex pipeline constitutes 15+ key companies continuously working towards developing 20+ Herpes Simplex

High-Grade Glioma Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, High-Grade Glioma pipeline constitutes 150+ key companies continuously working towards developing 150+ High-Grade Glioma

Prurigo Nodularis Pipeline Insights 2024: Therapies, Clinical Trials, and Therap …

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Prurigo Nodularis pipeline constitutes 5+ key companies continuously working towards developing 5+ Prurigo Nodularis

Sarcopenia Pipeline Analysis 2024: FDA Approvals, Medication, Clinical Trials, T …

(Albany, United States) As per DelveInsight's assessment, globally, Sarcopenia pipeline constitutes 10+ key companies continuously working towards developing 10+ Sarcopenia treatment therapies, analysis of Clinical

Thrombocytopenia Pipeline Analysis 2024: EMA, PDMA, FDA Approvals, Clinical Tria …

(Albany, United States) As per DelveInsight's assessment, globally, Thrombocytopenia pipeline constitutes 25+ key companies continuously working towards developing 25+ Thrombocytopenia treatment therapies, analysis of Clinical

Hepatic Encephalopathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Hepatic Encephalopathy pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatic Encephalopathy treatment therapies, analysis

Hemophilia B Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …

(Albany, USA) As per DelveInsight's assessment, globally, about 15+ key pharma and biotech companies are working on 20+ pipeline drugs in the Hemophilia B therapeutics

Homocystinuria Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies …

(Albany, United States) As per DelveInsight's assessment, globally, Homocystinuria pipeline constitutes 3+ key companies continuously working towards developing 3+ Homocystinuria treatment therapies, analysis of Clinical

Clostridium Difficile Infections Clinical Trials 2024: EMA, PDMA, FDA Approvals, …

(Albany, United States) As per DelveInsight's assessment, globally, Clostridium Difficile Infections pipeline constitutes 20+ key companies continuously working towards developing 22+ Clostridium Difficile Infections treatment

Complicated Urinary Tract Infection (UTI) Clinical Trials 2024: EMA, PDMA, FDA A …

(Albany, United States) As per DelveInsight's assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary

IgG4-Related Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, …

(Albany, United States) As per DelveInsight's assessment, globally, IgG4-Related Disease pipeline constitutes 10+ key companies continuously working towards developing 10+ IgG4-Related Disease treatment therapies, analysis

Acute Pain Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatment …

(Albany, United States) As per DelveInsight's assessment, globally, Acute Pain pipeline constitutes 25+ key companies continuously working towards developing 25+ Acute Pain treatment therapies, analysis

Acute On Chronic Liver Failure Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …

(Albany, United States) As per DelveInsight's assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 4+ key companies continuously working towards developing 6+ Acute On

PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, …

The prevalence of non-small cell lung cancer has been rising over the past few years, which prompts a growing demand for treatment options. The introduction

Fabry Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Treatm …

(Albany, United States) As per DelveInsight's assessment, globally, Fabry Disease pipeline constitutes 18+ key companies continuously working towards developing 18+ Fabry Disease treatment therapies, analysis

Systemic Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …

(Albany, USA) DelveInsight's, "Systemic Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Systemic Sclerosis pipeline landscape.

Ankylosing Spondylitis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …

(Albany, United States) As per DelveInsight's assessment, globally, Ankylosing Spondylitis pipeline constitutes 20+ key companies continuously working towards developing 20+ Ankylosing Spondylitis treatment therapies, analysis

NSCLC Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, Drug …

(Albany, USA) DelveInsight's, "Non-Small-Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 135+ NSCLC Companies and 150+ pipeline drugs in the Non-Small-Cell Lung

Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trials 2024: EMA, PDMA, FDA …

(Albany, USA) DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Non Muscle

Crohn's Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …

(Albany, United States) As per DelveInsight's assessment, globally, Crohn's Disease pipeline constitutes 70+ key companies continuously working towards developing 80+ Crohn's Disease treatment therapies, analysis

Go To Page:    21 22 23 24 25 26 27 28 29 30